EA201490100A1 - Противогрибковые и антибактериальные пролекарства на основе конъюгатов - Google Patents
Противогрибковые и антибактериальные пролекарства на основе конъюгатовInfo
- Publication number
- EA201490100A1 EA201490100A1 EA201490100A EA201490100A EA201490100A1 EA 201490100 A1 EA201490100 A1 EA 201490100A1 EA 201490100 A EA201490100 A EA 201490100A EA 201490100 A EA201490100 A EA 201490100A EA 201490100 A1 EA201490100 A1 EA 201490100A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- antibacterial
- afa
- antifungal
- conjugates
- procaracies
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
- A61K47/552—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being an antibiotic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Abstract
В изобретении предложены противогрибковые и антибактериальные пролекарства на основе конъюгата, получаемые путем связывания по меньшей мере одного противогрибкового или антибактериального агента по меньшей мере с одним линкером и/или носителем. Пролекарства имеют формулу: (i) (AFA)-X-(L); (ii) [(AFA)-X]-L; (iii) AFA-[X-(L)]или (iv) (AFA)-X, где AFA представляет собой противогрибковый или антибактериальный агент; L представляет собой носитель; X представляет собой линкер; m составляет от 1 до 10; n составляет от 2 до 10; m' составляет от 1 до 10; р составляет от 1 до 10; n' составляет от 1 до 10; q составляет от 1 до 10 при условии, что оба q' и n одновременно не равняются 1; и m" составляет от 1 до 10. В изобретении также предложены наночастицы, содержащие пролекарства на основе конъюгатов. Кроме того, в изобретении предложены неконъюгированные противогрибковые и антибактериальные агенты в форме наночастиц.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1770DE2011 | 2011-06-22 | ||
US201161514305P | 2011-08-02 | 2011-08-02 | |
PCT/US2012/043717 WO2012177986A2 (en) | 2011-06-22 | 2012-06-22 | Conjugate-based antifungal and antibacterial prodrugs |
Publications (3)
Publication Number | Publication Date |
---|---|
EA201490100A1 true EA201490100A1 (ru) | 2014-11-28 |
EA032840B1 EA032840B1 (ru) | 2019-07-31 |
EA032840B8 EA032840B8 (ru) | 2020-06-18 |
Family
ID=47423228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201490100A EA032840B8 (ru) | 2011-06-22 | 2012-06-22 | Пролекарства на основе конъюгатов противогрибковых агентов и их применение |
Country Status (11)
Country | Link |
---|---|
US (2) | US9907812B2 (ru) |
EP (1) | EP2723452A2 (ru) |
JP (2) | JP6336902B2 (ru) |
KR (1) | KR20140057414A (ru) |
CN (1) | CN103857440B (ru) |
AU (1) | AU2012272804B2 (ru) |
BR (1) | BR112013033239A2 (ru) |
CA (1) | CA2840215A1 (ru) |
EA (1) | EA032840B8 (ru) |
MX (1) | MX2013015434A (ru) |
WO (1) | WO2012177986A2 (ru) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2509159B (en) * | 2012-12-21 | 2017-07-26 | Oxoid Ltd | Triclosan derivatives and uses thereof |
EA201591954A1 (ru) * | 2013-04-12 | 2016-04-29 | Вайом Байосайнсиз Пвт. Лтд. | Композиция и состав противомикробных средств, способы их получения и способы лечения микробных инфекций |
US20140377356A1 (en) * | 2013-06-19 | 2014-12-25 | Professional Compounding Centers Of America (Pcca) | Inhalation Composition for Treating Respiratory Tract Infections |
CA2913174A1 (en) * | 2013-06-24 | 2014-12-31 | F. Hoffmann-La Roche Ag | Stable intravenous formulation |
WO2015023675A2 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
CN104422750B (zh) * | 2013-09-05 | 2016-02-10 | 中国科学院大连化学物理研究所 | 一种烟叶中磷脂酰乙醇胺与甘油三酯含量的检测方法 |
GB201317005D0 (en) * | 2013-09-25 | 2013-11-06 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
HUE032205T2 (en) | 2013-11-08 | 2017-09-28 | Lilly Co Eli | Atomoxetine solution |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
WO2015093661A1 (ko) * | 2013-12-19 | 2015-06-25 | (주)바이오에프디엔씨 | 항균펩타이드 베타-디펜신 3 및 3h의 라우릭산 융합을 통한 장기지속형 유도체, 세포투과성 펩타이드 융합을 통한 피부투과형 유도체 개발과 이를 함유하는 화장료 조성물 |
EP3698793A1 (en) | 2014-01-29 | 2020-08-26 | Vyome Therapeutics Limited | Besifloxacin for the treatment of resistant acne |
WO2015164289A1 (en) * | 2014-04-21 | 2015-10-29 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of fungal infections |
WO2016010771A1 (en) | 2014-07-17 | 2016-01-21 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
JP2017531026A (ja) | 2014-10-20 | 2017-10-19 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | 徐放性乱用抑止性液体充填剤形 |
US11478497B2 (en) * | 2014-12-18 | 2022-10-25 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and compositions for treating eukaryotic infections via altering aggregation dynamics of Raptor/KOG1 |
CN104627958B (zh) * | 2015-01-30 | 2016-03-16 | 四川大学 | 一种稳定性增强的改性纳米粒子及其制备方法 |
CN104971357B (zh) * | 2015-03-20 | 2018-04-17 | 南京星银药业集团有限公司 | Peg修饰的棘白菌素类抗真菌药物复合物及其制备 |
US20210393674A1 (en) * | 2015-09-20 | 2021-12-23 | Air Cross, Inc. | Ozonolysis for activation of compounds and degradation of ozone |
MX2018002514A (es) | 2015-09-22 | 2018-08-15 | Univ California | Citotoxinas modificadas y su uso terapeutico. |
US10286079B2 (en) | 2015-09-22 | 2019-05-14 | The Regents Of The University Of California | Modified cytotoxins and their therapeutic use |
CN105521020B (zh) * | 2015-11-17 | 2021-06-18 | 安徽师范大学 | 具有控制人体皮肤病活性的植物提取物组合物 |
BR112018010456B1 (pt) | 2015-12-14 | 2022-06-07 | Unilever Ip Holdings B.V. | Composição antimicrobiana, método para limpeza ou desinfecção de uma superfície e usos de uma composição |
CN106913520A (zh) * | 2015-12-25 | 2017-07-04 | 上海医药集团股份有限公司 | 艾沙康唑的微粒给药组合物 |
CN106551803A (zh) * | 2016-04-11 | 2017-04-05 | 张梦兮 | 吡罗克酮类化合物在制备预防口腔黏膜疾病的保健制品上的用途 |
WO2018031782A1 (en) * | 2016-08-10 | 2018-02-15 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Nanoparticle compositions and methods for enhanced stability and delivery of glycopeptide drugs |
WO2018033466A1 (en) | 2016-08-19 | 2018-02-22 | Unilever N.V. | An antimicrobial composition |
CN109640930B (zh) | 2016-08-19 | 2021-11-26 | 联合利华知识产权控股有限公司 | 抗微生物组合物 |
CN106307543B (zh) * | 2016-08-22 | 2020-02-07 | 青岛农业大学 | 一种麝香草酚纳米脂质体及其制备方法 |
CN106366285A (zh) * | 2016-09-09 | 2017-02-01 | 福州维亚生物科技有限公司 | 一种血管支架的制备和使用方法 |
KR102408798B1 (ko) | 2016-10-14 | 2022-06-13 | 풀매트릭스 오퍼레이팅 컴퍼니, 인크 | 항진균성 건조 분말 |
GB2555391B (en) * | 2016-10-21 | 2019-06-26 | Algipharma As | Bacitracin-alginate oligomer conjugates |
CN106432478B (zh) * | 2016-10-25 | 2019-10-11 | 齐鲁工业大学 | 一种胶原蛋白的抗菌改性方法 |
US11471396B2 (en) | 2016-10-28 | 2022-10-18 | Conopco, Inc. | Personal care compositions comprising surface-modified particles and non-volatile funcationalised silicone |
MX2019004869A (es) | 2016-10-28 | 2019-08-12 | Unilever Nv | Una composicion para el cuidado personal que comprende particulas. |
CN106727670B (zh) * | 2016-11-17 | 2019-06-14 | 温州医科大学 | 一种抗细菌兼抗真菌作用的胶束制剂及制备方法 |
IL287622B (en) | 2016-11-28 | 2022-07-01 | Cellix Bio Private Ltd | Preparations and methods for treating fungal infections |
CN106674224A (zh) * | 2016-12-20 | 2017-05-17 | 天津迈德新医药科技有限公司 | mPEG4‑阿巴卡韦及其制备方法和应用 |
CA3060510A1 (en) | 2017-04-21 | 2018-10-25 | Lunella Biotech, Inc. | Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs) |
US11229657B2 (en) | 2017-04-21 | 2022-01-25 | Lunella Biotech, Inc. | Targeting hypoxic cancer stem cells (CSCs) with doxycycline: implications for improving anti-angiogenic therapy |
US20200138964A1 (en) * | 2017-04-25 | 2020-05-07 | Seikagaku Corporation | Tertiary amine compound or imine compound-polymer conjugate and production method therefor |
BR112019024264A2 (pt) | 2017-05-19 | 2020-06-02 | Lunella Biotech, Inc. | Antimitoscinas: inibidores direcionados da biogênese mitoconcrial para erradicação de células-tronco de câncer |
CR20200033A (es) | 2017-06-26 | 2020-03-05 | Lunella Biotech Inc | Mitocetoscinas: agentes terapéuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en células cancerosas |
SE541313C2 (en) * | 2017-10-13 | 2019-06-25 | Amferia Ab | Amphiphilic antimicrobial hydrogel |
EP3713537A4 (en) * | 2017-11-22 | 2021-07-14 | Progeneron | TOPICAL COMPOSITIONS, THEIR MANUFACTURING PROCESS AND THEIR USE OF |
US11564963B2 (en) | 2017-11-22 | 2023-01-31 | Progeneron, Llc | Topical compositions, process of large-scale manufacture, and method of use |
WO2019109065A1 (en) * | 2017-12-01 | 2019-06-06 | The Children's Medical Center Corporation | Covalent anesthetic-polymer conjugates for prolonged local anesthesia |
CA3088889A1 (en) * | 2018-01-17 | 2019-07-25 | The Secant Group, Llc | Ph-modulating biodegradable polymer and poly(glycerol sebacate)-augmented cell culture media |
WO2019191597A1 (en) * | 2018-03-30 | 2019-10-03 | The Board Of Regents Of The University Of Oklahoma | Very long chain saturated fatty acid compounds, compositions containing same, and methods of use |
CN108524945B (zh) * | 2018-05-21 | 2019-12-17 | 广东海洋大学 | 一种庆大霉素改性壳聚糖的制备方法 |
CN108743603B (zh) * | 2018-06-22 | 2020-06-30 | 山东省千佛山医院 | 利巴韦林单用或联合氟康唑的抗真菌产品及其应用 |
US20220257781A1 (en) * | 2018-09-06 | 2022-08-18 | Seikagaku Corporation | Polymer conjugate bonded to tertiary amine compound or imine compound and production method therefor |
CN109528639A (zh) * | 2018-12-24 | 2019-03-29 | 江西润泽药业有限公司 | 一种用于制备复方盐酸林可霉素注射液的方法 |
JP7378929B2 (ja) * | 2018-12-27 | 2023-11-14 | 花王株式会社 | リポソームの製造方法 |
CN109679328B (zh) * | 2018-12-28 | 2021-08-24 | 山东一诺威体育产业有限公司 | 快速固化低温柔韧性聚氨酯粘合剂及其制备方法和使用方法 |
EP3962533A4 (en) | 2019-04-30 | 2023-01-25 | The Medical College of Wisconsin, Inc. | PLATFORM FOR THROAT ADMINISTRATION AND USES THEREOF |
EP3976197A4 (en) * | 2019-05-24 | 2023-07-19 | Lunella Biotech, Inc. | THERAPEUTIC AGENTS AND METHODS FOR PREDICTING AND OVERCOMING ENDOCRINE RESISTANCE IN BREAST CANCER |
JP2022542970A (ja) * | 2019-08-01 | 2022-10-07 | ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ | フケ防止組成物 |
JP2022542971A (ja) * | 2019-08-01 | 2022-10-07 | ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ | フケ防止組成物 |
US20220313717A1 (en) * | 2019-08-13 | 2022-10-06 | Matinas Biopharma Nanotechnologies, Inc. | Methods of treating cryptococcus infections |
KR102331879B1 (ko) * | 2019-09-20 | 2021-11-29 | 의료법인 성광의료재단 | 특수 코팅된 나노입자 및 그의 이용 |
CN110898230B (zh) * | 2019-12-27 | 2022-11-22 | 中国医学科学院放射医学研究所 | 一种基于三氯生的纳米抗生素水凝胶及其制备方法与应用 |
CN111440124B (zh) * | 2020-04-27 | 2023-01-17 | 中国海洋大学 | 一种5-氟尿嘧啶与咖啡酸的共晶及其制备方法 |
WO2021226166A1 (en) * | 2020-05-07 | 2021-11-11 | Liang Guibai | Prodrug of itraconazole and use thereof |
WO2021234527A1 (en) * | 2020-05-17 | 2021-11-25 | Abgenics Lifesciences Private Limited | An antibody fragment based antifungal conjugate selectively targeting candida |
CN111821512B (zh) * | 2020-06-19 | 2022-06-14 | 上海大学 | 酶响应释药聚l-谷氨酸/壳聚糖多孔复合微载体、其制备方法及其应用 |
CN111840264B (zh) * | 2020-08-14 | 2023-04-07 | 华中科技大学协和深圳医院 | 西塞卡那用于抑制革兰阳性细菌生物活性的用途 |
WO2022050369A1 (ja) * | 2020-09-04 | 2022-03-10 | 国立大学法人大阪大学 | 抗菌薬を含有するリポソーム製剤 |
KR20220035334A (ko) * | 2020-09-09 | 2022-03-22 | 난징 헤론 파마슈티컬 사이언스 앤 테크놀로지 컴퍼니 리미티드 | 아릴프로피온산 유도체, 약학적 조성물 및 이의 제조방법과 응용 |
RU2764574C1 (ru) * | 2020-10-16 | 2022-01-18 | Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук | Средство для лечения акне |
WO2022084929A1 (en) * | 2020-10-23 | 2022-04-28 | Universita' Degli Studi Di Modena E Reggio Emilia | Nanoparticles for transport across the blood-brain barrier |
CN112625071B (zh) * | 2020-12-30 | 2022-07-29 | 海南海神同洲制药有限公司 | 一种盐酸克林霉素棕榈酸酯的合成工艺 |
CN112914174B (zh) * | 2021-01-26 | 2023-06-30 | 成都中医药大学 | 一种抗菌除臭口罩及其制备方法 |
CN113082000B (zh) * | 2021-04-30 | 2022-11-15 | 哈尔滨职业技术学院 | Bs固体脂质纳米递药系统的制备方法及应用 |
BR102021019756A2 (pt) * | 2021-10-01 | 2023-04-18 | Chemyunion Ltda | Composição antissebogênica, formulação e uso da composição |
US11845736B2 (en) | 2021-10-01 | 2023-12-19 | Empathbio, Inc. | Prodrugs of MDMA, MDA, and derivatives thereof |
US11912680B2 (en) | 2021-12-28 | 2024-02-27 | Empathbio, Inc. | Nitric oxide releasing prodrugs of MDA and MDMA |
CN114230619A (zh) * | 2022-01-05 | 2022-03-25 | 浙江天台药业股份有限公司 | 一种盐酸克林霉素棕榈酸酯杂质的分离纯化方法 |
WO2023187197A1 (en) | 2022-03-31 | 2023-10-05 | Université De Genève | Conjugates of antimicrobial agents with a tocopheryl or tocotrienyl group |
CN116063746B (zh) * | 2022-08-18 | 2024-04-02 | 中国农业科学院深圳农业基因组研究所 | 提升壳聚糖材料机械性能的方法及制备的壳聚糖复合材料 |
CN115137733B (zh) * | 2022-08-24 | 2024-01-02 | 吉林大学 | 熊去氧胆酸在制备mcr-3酶抑制剂中的应用 |
WO2024058975A1 (en) * | 2022-09-14 | 2024-03-21 | Ultra, Llc | Modified cholic acid conjugates |
Family Cites Families (162)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2826551A (en) | 1954-01-04 | 1958-03-11 | Simoniz Co | Nontangling shampoo |
GB849433A (en) | 1957-08-22 | 1960-09-28 | Raymond Woolston | Hair washing preparations |
US3784694A (en) | 1963-02-22 | 1974-01-08 | Ciba Geigy Corp | Halogenated 2-acyloxy-diphenylethers as bactericides and fungicides |
US3958581A (en) | 1972-05-17 | 1976-05-25 | L'oreal | Cosmetic composition containing a cationic polymer and divalent metal salt for strengthening the hair |
CA1018893A (en) | 1972-12-11 | 1977-10-11 | Roger C. Birkofer | Mild thickened shampoo compositions with conditioning properties |
US3964500A (en) | 1973-12-26 | 1976-06-22 | Lever Brothers Company | Lusterizing shampoo containing a polysiloxane and a hair-bodying agent |
US4422853A (en) | 1974-05-16 | 1983-12-27 | L'oreal | Hair dyeing compositions containing quaternized polymer |
US4217914A (en) | 1974-05-16 | 1980-08-19 | L'oreal | Quaternized polymer for use as a cosmetic agent in cosmetic compositions for the hair and skin |
AT365448B (de) | 1975-07-04 | 1982-01-11 | Oreal | Kosmetische zubereitung |
US4197865A (en) | 1975-07-04 | 1980-04-15 | L'oreal | Treating hair with quaternized polymers |
US4313889A (en) * | 1975-09-22 | 1982-02-02 | Merck & Co., Inc. | Soft quaternary surface active agents |
US4204065A (en) | 1975-09-22 | 1980-05-20 | Interx Research Corporation | Soft quaternary surface active agents and method of using same |
US4177177A (en) | 1976-03-26 | 1979-12-04 | El Aasser Mohamed S | Polymer emulsification process |
US4152416A (en) | 1976-09-17 | 1979-05-01 | Marra Dorothea C | Aerosol antiperspirant compositions delivering astringent salt with low mistiness and dustiness |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4663158A (en) | 1979-07-02 | 1987-05-05 | Clairol Incorporated | Hair conditioning composition containing cationic polymer and amphoteric surfactant and method for use |
US4507280A (en) | 1979-07-02 | 1985-03-26 | Clairol Incorporated | Hair conditioning composition and method for use |
US4529586A (en) | 1980-07-11 | 1985-07-16 | Clairol Incorporated | Hair conditioning composition and process |
US4431809A (en) | 1981-04-13 | 1984-02-14 | Eli Lilly And Company | Antibiotic A-33853 derivatives |
US4364837A (en) | 1981-09-08 | 1982-12-21 | Lever Brothers Company | Shampoo compositions comprising saccharides |
US4942162A (en) | 1982-03-31 | 1990-07-17 | University Of Tennessee Research Corporation | Topical treatment of seborrheic dermatitis with ketoconazole |
GB8313634D0 (en) * | 1982-06-18 | 1983-06-22 | Ici Plc | Halogenophenyl glyceride esters |
US4588525A (en) | 1984-02-27 | 1986-05-13 | Molecular Biosystems, Inc. | Prodrug compounds for dermal application |
DE3584218D1 (de) | 1984-10-09 | 1991-10-31 | Lilly Co Eli | Herstellung von derivaten von a-21978c. |
USRE34584E (en) | 1984-11-09 | 1994-04-12 | The Procter & Gamble Company | Shampoo compositions |
CA1261276A (en) | 1984-11-09 | 1989-09-26 | Mark B. Grote | Shampoo compositions |
US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
DE3531971A1 (de) | 1985-09-07 | 1987-03-19 | Henkel Kgaa | Oel-in-wasser-emulsion |
US4737323A (en) | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
FR2598420B1 (fr) | 1986-05-06 | 1991-06-07 | Oreal | Nouveaux esters retinoiques d'antibiotiques, leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant |
AU618517B2 (en) | 1986-12-23 | 1992-01-02 | Eugene J. Van Scott | Additives enhancing topical actions of therapeutic agents |
FR2608942B1 (fr) | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules |
DE3805882C1 (ru) | 1988-02-25 | 1989-07-13 | Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh, 1000 Berlin, De | |
JPH02204413A (ja) | 1989-02-02 | 1990-08-14 | Nonogawa Shoji:Kk | 抗真菌外用製剤 |
FR2645866B1 (fr) | 1989-04-17 | 1991-07-05 | Centre Nat Rech Scient | Nouvelles lipopolyamines, leur preparation et leur emploi |
AU5858690A (en) * | 1989-06-14 | 1991-01-08 | Cetus Corporation | Polymer/antibiotic conjugate |
US5106609A (en) | 1990-05-01 | 1992-04-21 | The Procter & Gamble Company | Vehicle systems for use in cosmetic compositions |
US5104646A (en) | 1989-08-07 | 1992-04-14 | The Procter & Gamble Company | Vehicle systems for use in cosmetic compositions |
ES2098921T3 (es) | 1993-01-21 | 1997-05-01 | Janssen Pharmaceutica Nv | Composiciones de cetoconazol de uso topico. |
US5576016A (en) | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
DE4404018A1 (de) | 1994-02-09 | 1995-08-10 | Merck Patent Gmbh | Protrahiert freisetzende Darreichungsformen enthaltend Clindamycin-Palmitat |
US5456851A (en) | 1994-04-07 | 1995-10-10 | Johnson & Johnson Consumer Products, Inc. | Ketoconazole shampoo containing butylated hydroxytoluene or butylated hydroxyanisole |
TW460296B (en) | 1994-09-01 | 2001-10-21 | Janssen Pharmaceutica Nv | Topical ketoconazole emulsion compositions without sodium sulfite |
IL115849A0 (en) | 1994-11-03 | 1996-01-31 | Merz & Co Gmbh & Co | Tangential filtration preparation of liposomal drugs and liposome product thereof |
WO1996037194A1 (en) | 1995-05-26 | 1996-11-28 | Somatix Therapy Corporation | Delivery vehicles comprising stable lipid/nucleic acid complexes |
US6013250A (en) | 1995-06-28 | 2000-01-11 | L'oreal S. A. | Composition for treating hair against chemical and photo damage |
US5607980A (en) | 1995-07-24 | 1997-03-04 | The Procter & Gamble Company | Topical compositions having improved skin feel |
ES2162125T3 (es) | 1995-12-16 | 2001-12-16 | Planton Gmbh | Proteinas de vertebrados eficaces contra bacterias, hongos y virus y sus preparados cosmeticos. |
US5674478A (en) | 1996-01-12 | 1997-10-07 | The Procter & Gamble Company | Hair conditioning compositions |
US5750122A (en) | 1996-01-16 | 1998-05-12 | The Procter & Gamble Company | Compositions for treating hair or skin |
TW446563B (en) | 1996-01-16 | 2001-07-21 | Colgate Palmolive Co | Low static conditioning shampoo |
GB9602080D0 (en) | 1996-02-02 | 1996-04-03 | Pfizer Ltd | Pharmaceutical compounds |
US7094422B2 (en) | 1996-02-19 | 2006-08-22 | Acrux Dds Pty Ltd. | Topical delivery of antifungal agents |
US5847003A (en) | 1996-06-04 | 1998-12-08 | Avon Products, Inc. | Oxa acids and related compounds for treating skin conditions |
CA2261887C (en) * | 1996-07-23 | 2007-10-02 | Oregon Health Sciences University | Covalent polar lipid conjugates with biologically-active compounds for use in salves |
NZ328607A (en) * | 1996-09-09 | 1999-08-30 | Hoffmann La Roche | Heterocyclically substituted n-benzyl-azolium derivatives and fungicidal compositions |
EP0829478A3 (en) | 1996-09-09 | 1998-03-25 | F. Hoffmann-La Roche Ag | N-Benzylimidazolium and N-benzyltriazolium derivatives, their preparation and their use as antifungal and antimycotic agents |
JP3545588B2 (ja) | 1997-03-24 | 2004-07-21 | 株式会社資生堂 | 毛髪化粧料 |
JP3108997B2 (ja) * | 1997-03-31 | 2000-11-13 | 武田薬品工業株式会社 | アゾール化合物、その製造法および用途 |
US6207142B1 (en) | 1997-04-14 | 2001-03-27 | Janssen Pharmaceutica N.V. | Compositions containing an antifungal and a cationic agent |
US6599513B2 (en) | 1997-05-27 | 2003-07-29 | Sembiosys Genetics Inc. | Products for topical applications comprising oil bodies |
WO1999031036A2 (en) * | 1997-12-12 | 1999-06-24 | Ciba Specialty Chemicals Holding Inc. | O-derivatives of halogenated diphenyl ether compounds |
US6099870A (en) | 1997-12-18 | 2000-08-08 | Johnson & Johnson Consumer Companies, Inc. | Methods for improving the health of hair and scalp |
FR2774588B1 (fr) | 1998-02-11 | 2000-05-05 | Oreal | Composition cosmetique ou dermatologique contenant au moins une proteine de soie d'arachnides naturelle, recombinante ou un analogue |
US6265584B1 (en) | 1998-05-22 | 2001-07-24 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
US6284234B1 (en) | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
JP2000086655A (ja) * | 1998-09-16 | 2000-03-28 | Takeda Chem Ind Ltd | トリアゾール化合物、その製造法および用途 |
FR2787728B1 (fr) | 1998-12-23 | 2001-01-26 | Oreal | Nanoemulsion a base d'esters gras d'acide phosphorique, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique |
KR20000051143A (ko) | 1999-01-19 | 2000-08-16 | 김충섭 | 불소화 비닐기가 치환된 신규의 아졸계 유도체 및 그의 제조방법 |
US6235728B1 (en) | 1999-02-19 | 2001-05-22 | Bristol-Myers Squibb Company | Water-soluble prodrugs of azole compounds |
US6492326B1 (en) | 1999-04-19 | 2002-12-10 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
EP1176985A2 (en) | 1999-04-28 | 2002-02-06 | Vectramed, Inc. | Enzymatically activated polymeric drug conjugates |
US6451300B1 (en) | 1999-05-03 | 2002-09-17 | The Procter & Gamble Company | Anti-dandruff and conditioning shampoos containing polyalkylene glycols and cationic polymers |
US6974569B2 (en) | 1999-05-03 | 2005-12-13 | The Procter & Gamble Company | Shampoos providing a superior combination anti-dandruff efficacy and condition |
US6649155B1 (en) | 1999-05-03 | 2003-11-18 | The Procter & Gamble Company | Anti-dandruff and conditioning shampoos containing certain cationic polymers |
US6495498B2 (en) | 1999-05-27 | 2002-12-17 | Johnson & Johnson Consumer Companies, Inc. | Detergent compositions with enhanced depositing, conditioning and softness capabilities |
CA2309373A1 (en) * | 1999-05-27 | 2000-11-27 | Johnson & Johnson Consumer Companies, Inc. | Novel topical formulations |
US6524594B1 (en) | 1999-06-23 | 2003-02-25 | Johnson & Johnson Consumer Companies, Inc. | Foaming oil gel compositions |
FR2795315B1 (fr) | 1999-06-25 | 2001-08-10 | Oreal | Compositions cosmetiques contenant un polymere amphotere et un agent antipelliculaire et leurs utilisations |
DE19938404A1 (de) | 1999-08-13 | 2001-02-22 | Clariant Gmbh | Kosmetische Zubereitungen |
KR100360827B1 (ko) | 1999-08-14 | 2002-11-18 | 주식회사 삼양사 | 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법 |
US6669951B2 (en) | 1999-08-24 | 2003-12-30 | Cellgate, Inc. | Compositions and methods for enhancing drug delivery across and into epithelial tissues |
US6812238B1 (en) | 1999-11-02 | 2004-11-02 | Basilea Pharmaceutica Ag | N-substituted carbamoyloxyalkyl-azolium derivatives |
PT1280795E (pt) | 1999-11-02 | 2005-06-30 | Basilea Pharmaceutica Ag | Derivados de carbamoiloalquil-azolio n-substituidos |
DE19961278A1 (de) | 1999-12-18 | 2001-06-21 | Cognis Deutschland Gmbh | Verwendung von nanoskaligen Antischuppenwirkstoffen |
US20030206958A1 (en) | 2000-12-22 | 2003-11-06 | Cattaneo Maurizio V. | Chitosan biopolymer for the topical delivery of active agents |
US6967023B1 (en) | 2000-01-10 | 2005-11-22 | Foamix, Ltd. | Pharmaceutical and cosmetic carrier or composition for topical application |
US6362172B2 (en) | 2000-01-20 | 2002-03-26 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
EP1278755A2 (en) | 2000-03-07 | 2003-01-29 | Ranbaxy Laboratories, Limited | Azole compounds as therapeutic agents for fungal infections |
GB2365770B (en) | 2000-08-18 | 2002-07-31 | Diomed Dev Ltd | Antifungal ketoconazole composition for topical use |
US6448401B1 (en) | 2000-11-20 | 2002-09-10 | Bristol-Myers Squibb Company | Process for water soluble azole compounds |
US20030045678A1 (en) | 2000-12-18 | 2003-03-06 | Dennis Keith | Methods for preparing purified lipopeptides |
US6491902B2 (en) | 2001-01-29 | 2002-12-10 | Salvona Llc | Controlled delivery system for hair care products |
US6673373B2 (en) | 2001-02-01 | 2004-01-06 | Carlsbad Technology Inc. | Antifungal formulation and the methods for manufacturing and using the same |
WO2002067880A1 (en) | 2001-02-27 | 2002-09-06 | Unilever Plc | Treatment of dandruff |
US20050209157A1 (en) | 2001-03-28 | 2005-09-22 | Owen Donald R | Short bioactive peptides and methods for their use |
FR2824325B1 (fr) | 2001-05-04 | 2003-08-15 | Aventis Pharma Sa | Nouveaux derives d'azole ou de triazole, leur procede de preparation et leur application comme fongicides |
US6797697B2 (en) | 2001-05-21 | 2004-09-28 | Johnson & Johnson Consumer Companies, Inc. | Composition containing a peptide and a pigment and the use thereof in darkening the skin |
US20090317502A1 (en) | 2001-06-15 | 2009-12-24 | Cuticeuticals, Inc. | Dandruff treatment compositions with anti-inflammatory agents including botanic seed oils |
WO2003006009A1 (en) | 2001-07-11 | 2003-01-23 | Zen-Bio, Inc. | Compositions for reducing or preventing cellulite in mammalian skin |
IN191819B (ru) | 2001-07-19 | 2004-01-03 | Ranbaxy Lab Ltd | |
AU2003211113B2 (en) * | 2002-02-15 | 2007-08-09 | Merckle Gmbh | Antibiotic conjugates |
US20050131041A1 (en) | 2002-04-17 | 2005-06-16 | Mohammad Salman | Azole derivatives as antifungal agents |
CA2482038A1 (en) | 2002-04-22 | 2003-10-30 | The Procter & Gamble Company | Shampoo containing a cationic guar derivative |
FR2839448A1 (fr) | 2002-05-07 | 2003-11-14 | Oreal | Utilisation d'esters de triclosan, de piroctone et de tropolone dans une composition a liberation controlee |
US8361448B2 (en) | 2002-06-04 | 2013-01-29 | The Procter & Gamble Company | Shampoo containing a gel network |
US8367048B2 (en) | 2002-06-04 | 2013-02-05 | The Procter & Gamble Company | Shampoo containing a gel network |
US8349301B2 (en) | 2002-06-04 | 2013-01-08 | The Procter & Gamble Company | Shampoo containing a gel network |
WO2004018485A1 (en) | 2002-08-26 | 2004-03-04 | Ranbaxy Laboratories Limited | Azole derivatives as antifungal agents |
AU2003266643A1 (en) | 2002-09-27 | 2004-04-19 | Mochida Pharmaceutical Co., Ltd. | Cleansing composition containing antifungal agent and antibacterial agent |
TW200407172A (en) | 2002-10-17 | 2004-05-16 | Unilever Nv | Scalp treatment |
US20080200539A1 (en) | 2002-11-07 | 2008-08-21 | Bommarito Alexander A | Topical antifungal treatment |
US7091185B2 (en) | 2003-02-24 | 2006-08-15 | Dow Global Technologies Inc. | Periodic antimicrobial peptides |
US20050142094A1 (en) | 2003-03-12 | 2005-06-30 | Manoj Kumar | Use of repeat sequence protein polymers in personal care compositions |
US20040202636A1 (en) | 2003-04-11 | 2004-10-14 | Kaczvinsky Joseph Robert | Personal care composition containing an antidandruff component and a nonionic surfactant |
EP1617833A4 (en) * | 2003-04-18 | 2006-05-24 | Lighthouse Innovations Llc | COMPOSITIONS AND METHODS FOR TREATING BODY ODOR AND MUSHROOM GROWTH IN MAMMALS |
AU2004249165A1 (en) | 2003-06-17 | 2004-12-29 | Cognis Deutschland Gmbh & Co. Kg | Modified soy proteins in skin tightening compositions |
EP1646284A4 (en) | 2003-07-18 | 2008-09-24 | Rhode Island Education | AZOL DERIVATIVES AND METHOD FOR THEIR PREPARATION |
US7250398B2 (en) | 2003-09-12 | 2007-07-31 | Novozymes A/S | Synthetic antimicrobial polypeptides |
WO2005090385A2 (en) | 2004-03-18 | 2005-09-29 | Ansata Therapeutics, Inc. | Compositions having antimicrobial activity and uses thereof |
US20050245452A1 (en) | 2004-03-29 | 2005-11-03 | Novozymes A/S | Pharmaceutical use of novispirins |
US20060008538A1 (en) | 2004-07-07 | 2006-01-12 | Wu Jeffrey M | Methods of treating the skin |
US20060047135A1 (en) | 2004-08-30 | 2006-03-02 | Chadwick Scott T | Process for preparing chloromethyl di-tert-butylphosphate |
WO2006029818A2 (en) | 2004-09-16 | 2006-03-23 | Dsm Ip Assets B.V. | Cosmetic compositions containing an hydroxamic acid compound optionally in combination with a retinoid |
US8916050B2 (en) | 2004-09-27 | 2014-12-23 | Special Water Patents B.V. | Methods and compositions for treatment of water |
US20060110415A1 (en) | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
JP5055263B2 (ja) | 2005-03-30 | 2012-10-24 | ダエウン ファーマシューティカル カンパニー リミテッド | 抗真菌性トリアゾール誘導体 |
ES2368078T3 (es) | 2005-04-07 | 2011-11-14 | Toyama Chemical Co., Ltd. | Composición farmacéutica y método que usa un agente antifúngico en combinación. |
US7926484B2 (en) | 2005-05-03 | 2011-04-19 | Aeon Research And Technology, Inc. | Interface accessory for use with an aerosol inhalation system |
US20090209508A1 (en) | 2005-05-16 | 2009-08-20 | Universite De Geneve | Compounds for Photochemotherapy |
EP1922067A1 (en) | 2005-08-11 | 2008-05-21 | Medical College Of Georgia Research Institute | Modified green tea polyphenol formulations |
JP4706435B2 (ja) | 2005-10-26 | 2011-06-22 | 日油株式会社 | 化粧料、化粧料用ナノ粒子及び化粧料用粉体 |
JP2009513698A (ja) | 2005-10-31 | 2009-04-02 | デウン ファーマシューティカル カンパニー リミテッド | 新規な抗菌トリアゾール誘導体 |
US7858581B2 (en) | 2005-12-15 | 2010-12-28 | E. I. Du Pont De Nemours And Company | PMMA binding peptides and methods of use |
US20070292404A1 (en) | 2006-03-27 | 2007-12-20 | Biosynexus Incorporated | Antimicrobial polymer conjugates |
WO2007134245A2 (en) | 2006-05-12 | 2007-11-22 | Wisconsin Alumni Research Foundation | Elastin-like polymer delivery vehicles |
MX2009000211A (es) | 2006-07-07 | 2009-01-22 | Unilever Nv | Composiciones acondicionadoras de cabello anti-caspa. |
GB0613925D0 (en) | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
US20080032994A1 (en) | 2006-08-03 | 2008-02-07 | Marcel Borgers | Modified azole compounds as antifungal and antibacterial agents |
EP2102144A4 (en) * | 2006-09-13 | 2011-03-23 | Univ Rutgers | ACTIVE SUBSTANCES AND THEIR OLIGOMERS AND POLYMERS |
WO2008073558A2 (en) | 2006-10-05 | 2008-06-19 | The Johns Hopkins University | Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles |
EP1923041A1 (de) | 2006-10-20 | 2008-05-21 | Symrise GmbH & Co. KG | Verwendung von C10-C14-Alkandiolen zur Herstellung eines Mittels zur Prophylaxe und/oder Behandlung von Malassezia-induzierter Schuppenbildung, sowie Zubereitungen enthaltend C10-C14-Alkandiole |
KR100757237B1 (ko) | 2006-12-28 | 2007-09-10 | 김지활 | 탈모방지 및 발모촉진 기능을 갖는 나노입자 조성물 |
KR20080062876A (ko) | 2006-12-29 | 2008-07-03 | 주식회사 대웅제약 | 신규한 항진균성 트리아졸 유도체 |
EP2125014A2 (en) | 2007-01-16 | 2009-12-02 | Enzon Pharmaceuticals, Inc. | Posaconazole polymer conjugates and methods of treatment using posaconazole and polymer conjugates thereof |
WO2009006212A1 (en) | 2007-06-29 | 2009-01-08 | Union Carbide Chemicals & Plastics Technology Llc | Hair styling and conditioning personal care films |
US8053591B2 (en) | 2007-09-26 | 2011-11-08 | Bezwada Biomedical, Llc | Functionalized biodegradable triclosan monomers and oligomers for controlled release |
WO2009053163A1 (en) | 2007-10-25 | 2009-04-30 | Unilever Plc | Hair care composition |
EP2214629B1 (en) | 2007-12-06 | 2016-01-27 | Unilever PLC | Personal care composition |
EP2596805B1 (en) | 2008-02-01 | 2021-10-27 | Ascendis Pharma A/S | Prodrug comprising a drug-linker conjugate |
WO2009129301A2 (en) | 2008-04-15 | 2009-10-22 | Schering Corporation | Oral pharmaceutical compositions in a molecular solid dispersion |
AU2009240389A1 (en) | 2008-04-25 | 2009-10-29 | Nanobio Corporation | Nanoemulsions for treating fungal, yeast and mold infections |
WO2010010568A1 (en) | 2008-07-22 | 2010-01-28 | Lupin Limited | Oral compositions of clindamycin |
JP5288967B2 (ja) | 2008-09-22 | 2013-09-11 | ユー・ディー・シー アイルランド リミテッド | 発光素子及びその製造方法、並びに該発光素子を備えるディスプレイ |
EP2218447B1 (en) | 2008-11-04 | 2017-04-19 | PharmaSol GmbH | Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles |
FR2940281B1 (fr) * | 2008-12-22 | 2011-04-01 | Fabre Pierre Dermo Cosmetique | Ester de diol et d'acide gras polyinsature comme agent anti-acne |
US8124577B2 (en) | 2009-01-21 | 2012-02-28 | Stepan Company | Personal care compositions of sulfonated estolides and other derivatives of fatty acids and uses thereof |
CN105919820A (zh) | 2009-05-08 | 2016-09-07 | 荷兰联合利华有限公司 | 组合物 |
ES2548998T3 (es) | 2009-05-29 | 2015-10-22 | Palau Pharma, S.A. | Composiciones antifúngicas de azol |
CN102802593A (zh) | 2009-06-24 | 2012-11-28 | 荷兰联合利华有限公司 | 基于凝胶网络的去头屑洗发剂 |
ES2647361T3 (es) | 2010-01-07 | 2017-12-21 | Alkermes Pharma Ireland Limited | Profármacos de sales de amonio cuaternario |
US20110166128A1 (en) | 2010-01-07 | 2011-07-07 | Alkermes, Inc. | Diaryldiazepine Prodrugs for the Treatment of Neurological and Psychological Disorders |
-
2012
- 2012-06-22 CN CN201280040827.4A patent/CN103857440B/zh not_active Expired - Fee Related
- 2012-06-22 CA CA2840215A patent/CA2840215A1/en not_active Abandoned
- 2012-06-22 JP JP2014517203A patent/JP6336902B2/ja active Active
- 2012-06-22 MX MX2013015434A patent/MX2013015434A/es unknown
- 2012-06-22 WO PCT/US2012/043717 patent/WO2012177986A2/en active Application Filing
- 2012-06-22 BR BR112013033239A patent/BR112013033239A2/pt not_active IP Right Cessation
- 2012-06-22 KR KR1020147001853A patent/KR20140057414A/ko not_active Application Discontinuation
- 2012-06-22 AU AU2012272804A patent/AU2012272804B2/en not_active Ceased
- 2012-06-22 US US14/128,281 patent/US9907812B2/en active Active
- 2012-06-22 EA EA201490100A patent/EA032840B8/ru not_active IP Right Cessation
- 2012-06-22 EP EP12731271.8A patent/EP2723452A2/en not_active Withdrawn
-
2018
- 2018-01-23 US US15/878,305 patent/US20180214472A1/en not_active Abandoned
- 2018-02-13 JP JP2018022696A patent/JP2018100285A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2012177986A3 (en) | 2013-03-14 |
EP2723452A2 (en) | 2014-04-30 |
AU2012272804B2 (en) | 2017-07-06 |
AU2012272804A1 (en) | 2014-01-16 |
US9907812B2 (en) | 2018-03-06 |
KR20140057414A (ko) | 2014-05-12 |
US20180214472A1 (en) | 2018-08-02 |
EA032840B1 (ru) | 2019-07-31 |
BR112013033239A2 (pt) | 2016-09-06 |
WO2012177986A2 (en) | 2012-12-27 |
JP6336902B2 (ja) | 2018-06-06 |
CN103857440B (zh) | 2018-09-25 |
EA032840B8 (ru) | 2020-06-18 |
CN103857440A (zh) | 2014-06-11 |
NZ619293A (en) | 2017-03-31 |
US20140364595A1 (en) | 2014-12-11 |
CA2840215A1 (en) | 2012-12-27 |
JP2014522816A (ja) | 2014-09-08 |
MX2013015434A (es) | 2014-10-14 |
JP2018100285A (ja) | 2018-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201490100A1 (ru) | Противогрибковые и антибактериальные пролекарства на основе конъюгатов | |
NZ705394A (en) | Antibody-drug conjugate | |
PH12017502300A1 (en) | Pesticidal compositions and processes related thereto | |
PH12015501392A1 (en) | Pesticidal compositions and processes related thereto | |
MX346665B (es) | Composiciones pesticidas y procedimientos relacionados con estas. | |
MX2012001665A (es) | Compuestos antiproliferativos, conjugados de los mismos, procedimientos para estos, y usos de los mismos. | |
MA34677B1 (fr) | Compositions pesticides et procedes apprentes | |
SG10201804331TA (en) | Oligonucleotide conjugates | |
WO2013162716A3 (en) | Pesticidal compositions and processes related thereto | |
EA201992456A2 (ru) | Самостабилизирующиеся линкерные конъюгаты | |
EA200801959A1 (ru) | Высокоразветвленный полипропилен | |
EA201490518A1 (ru) | Пирролбензодиазепины | |
EA201290838A1 (ru) | Конъюгаты пирролбензодиазепина направленного действия | |
NZ588884A (en) | Cross-linkers and their uses | |
UA111341C2 (uk) | Аматоксиновий кон'югат з покращеними лінкерами | |
EA201290506A1 (ru) | Частицы для доставки множества агентов | |
EA201590424A1 (ru) | Пирролбензодиазепины и их конъюгаты | |
EA201200122A1 (ru) | КОНЬЮГАТЫ ε-ПОЛИЛИЗИНА И ИХ ПРИМЕНЕНИЕ | |
WO2014089177A3 (en) | Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines | |
AU2010246102A8 (en) | Pesticidal compositions | |
CR11454A (es) | Derivados de isoxazolo-piridina | |
WO2012047762A3 (en) | Antifungal agents | |
EA200870615A1 (ru) | Производные лептомицина | |
WO2012144847A3 (ko) | 은 잉크 조성물 | |
WO2013103301A3 (en) | Method for preparing cell targeting conjugates, and the complexes obtained |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM RU |